InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Jensen Thomas, Chief Executive Officer. Officer active across 1 company, notably Allarity Therapeutics, Inc.. Aggregated, 3 disclosures have been recorded. Activity tracked since 22 January 2025. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Jensen Thomas is the CEO of Allarity Therapeutics, Inc. He oversees the company's operations and is responsible for the overall strategy. His leadership is essential for growth and innovation in the biotechnology sector.